Retinopathy Associated with Adjuvant Interferon in a Patient with Malignant Melanoma: A Case Report and Review of the Literature
Ophthalmology Research: An International Journal · pp. 1–7 · Published 27 Nov 2019
10.9734/or/2019/v11i230121Abstract
Interferons are kinds of proteins with immuneregulatory, antiviral and anti-proliferative functions. Interferons are widely used worldwide for the treatment of many diseases including cancer, hepatit C and immune mediated disease such as multiple sclerosis. Long-term use of interferons have some side effects. However, interferons have ophthalmologic side effects. Ocular toxicity may occur at any time during treatment. There is no association between the dose or duration of interferon treatment and ocular toxicity. Although visual acuity returns to normal in most patients when interferon is discontinued, vision loss may be permanent.
Cited by 0
No indexed citations yet.
Related research
- Anal Melanoma: An Atypical Case — shares topic coverage
- All-Trans Retinoic Acid Downregulates Epidermal Growth Factor Receptor Mediated Regulation of Matrix Metalloproteinase-2 in B16F10 Murine Melanoma Cells — shares topic coverage
- Diagnosis of Melanoma Based on the Sparse Auto-Encoder for Feature Extraction — shares topic coverage
- Therapeutic Effect of Hydatid Cyst Liquid on Melanoma Tumor Growth in Mouse Model — shares topic coverage
- Panophthalmitis Masquerading as Ocular Melanoma-an Eye Opener — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.